- $746.04m
- $843.60m
- $423.43m
- 62
- 61
- 83
- 77
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 60.4 | 79.4 | 171 | 341 | 423 |
Cost of Revenue | |||||
Gross Profit | 56.8 | 75.1 | 127 | 234 | 297 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 140 | 121 | 244 | 576 | 455 |
Operating Profit | -79.1 | -41.6 | -73.4 | -235 | -31.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -79.1 | -41.6 | -169 | -215 | -46.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -79.1 | -41.6 | -169 | -189 | -45.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -88.8 | -50 | -182 | -189 | -45.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -103 | -67.2 | -140 | -196 | -44.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.8 | -7.68 | -41.3 | -12.3 | -2.11 |